Timing and severity of initial hepatitis C recurrence as predictors of long-term liver allograft injury

Hugo R. Rosen, David R. Gretch, Megan Oehlke, Kenneth D. Flora, Kent G. Benner, John M. Rabkin, Christopher Corless

Research output: Contribution to journalArticle

112 Citations (Scopus)

Abstract

Background. The majority of patients infected with hepatitis C virus (HCV) undergoing liver transplantation develop evidence of histologic recurrence, and multiple mechanisms are likely poised to affect longterm allograft injury. The purpose of this analysis was to study the hypothesis that histologic and biochemical features at the onset of HCV recurrence predict the long-term evolution of allograft hepatitis. Methods. We studied 34 consecutive liver transplant recipients with evidence of histologic HCV recurrence and with a minimal histologic follow-up of 1 year (up to 6.2 years; mean: 696±83.2 days). Two-hundred and seventy-eight serial allograft biopsies (mean: 6.85±0.62 per patient, range: 4-21) were analyzed. The hepatic activity index was utilized to quantitate piecemeal necrosis, intralobular degeneration, portal inflammation, and hepatic fibrosis. The presence of hepatocyte ballooning degeneration and cholestasis was also assessed. Results. Although there was no significant difference with regard to initial hepatic activity index scores between patients who ultimately developed allograft cirrhosis (group 1; n=8) versus those with milder hepatitis (group 2; n=26), the finding of ballooning degeneration/cholestasis was more frequent in the former group (P=0.04). The distribution of HCV genotypes, the mean follow-up after orthotopic liver transplantation, the mean number of allograft biopsy specimens per patient, basal immunosuppression, and incidence of rejection were comparable in both groups. Patients who ultimately developed allograft cirrhosis had significantly higher initial total bilirubin at the onset of histologic recurrence and peak total bilirubin (pT.Bili, the highest value in the ensuing month). Actuarial rates of moderate-to-severe allograft hepatitis were significantly greater in patients with pT.Bili ≤3.5 mg/dl (P=0.004). Multiple regression analysis identified pT.Bili as the only independent predictor of allograft cirrhosis. Conclusions. Features at the onset of histologic HCV recurrence predict the natural history of allograft injury; specifically, marked, transient hyperbilirubinemia is associated with the subsequent development of allograft cirrhosis.

Original languageEnglish (US)
Pages (from-to)1178-1182
Number of pages5
JournalTransplantation
Volume65
Issue number9
DOIs
StatePublished - May 15 1998

Fingerprint

Hepatitis C
Allografts
Recurrence
Liver
Wounds and Injuries
Hepacivirus
Fibrosis
Hepatitis
Cholestasis
Bilirubin
Liver Transplantation
Biopsy
Hyperbilirubinemia
Natural History
Immunosuppression
Hepatocytes
Necrosis
Genotype
Regression Analysis
Inflammation

ASJC Scopus subject areas

  • Transplantation
  • Immunology

Cite this

Timing and severity of initial hepatitis C recurrence as predictors of long-term liver allograft injury. / Rosen, Hugo R.; Gretch, David R.; Oehlke, Megan; Flora, Kenneth D.; Benner, Kent G.; Rabkin, John M.; Corless, Christopher.

In: Transplantation, Vol. 65, No. 9, 15.05.1998, p. 1178-1182.

Research output: Contribution to journalArticle

Rosen, Hugo R. ; Gretch, David R. ; Oehlke, Megan ; Flora, Kenneth D. ; Benner, Kent G. ; Rabkin, John M. ; Corless, Christopher. / Timing and severity of initial hepatitis C recurrence as predictors of long-term liver allograft injury. In: Transplantation. 1998 ; Vol. 65, No. 9. pp. 1178-1182.
@article{00c45092625f47a7bbab03bcc70f0dc4,
title = "Timing and severity of initial hepatitis C recurrence as predictors of long-term liver allograft injury",
abstract = "Background. The majority of patients infected with hepatitis C virus (HCV) undergoing liver transplantation develop evidence of histologic recurrence, and multiple mechanisms are likely poised to affect longterm allograft injury. The purpose of this analysis was to study the hypothesis that histologic and biochemical features at the onset of HCV recurrence predict the long-term evolution of allograft hepatitis. Methods. We studied 34 consecutive liver transplant recipients with evidence of histologic HCV recurrence and with a minimal histologic follow-up of 1 year (up to 6.2 years; mean: 696±83.2 days). Two-hundred and seventy-eight serial allograft biopsies (mean: 6.85±0.62 per patient, range: 4-21) were analyzed. The hepatic activity index was utilized to quantitate piecemeal necrosis, intralobular degeneration, portal inflammation, and hepatic fibrosis. The presence of hepatocyte ballooning degeneration and cholestasis was also assessed. Results. Although there was no significant difference with regard to initial hepatic activity index scores between patients who ultimately developed allograft cirrhosis (group 1; n=8) versus those with milder hepatitis (group 2; n=26), the finding of ballooning degeneration/cholestasis was more frequent in the former group (P=0.04). The distribution of HCV genotypes, the mean follow-up after orthotopic liver transplantation, the mean number of allograft biopsy specimens per patient, basal immunosuppression, and incidence of rejection were comparable in both groups. Patients who ultimately developed allograft cirrhosis had significantly higher initial total bilirubin at the onset of histologic recurrence and peak total bilirubin (pT.Bili, the highest value in the ensuing month). Actuarial rates of moderate-to-severe allograft hepatitis were significantly greater in patients with pT.Bili ≤3.5 mg/dl (P=0.004). Multiple regression analysis identified pT.Bili as the only independent predictor of allograft cirrhosis. Conclusions. Features at the onset of histologic HCV recurrence predict the natural history of allograft injury; specifically, marked, transient hyperbilirubinemia is associated with the subsequent development of allograft cirrhosis.",
author = "Rosen, {Hugo R.} and Gretch, {David R.} and Megan Oehlke and Flora, {Kenneth D.} and Benner, {Kent G.} and Rabkin, {John M.} and Christopher Corless",
year = "1998",
month = "5",
day = "15",
doi = "10.1097/00007890-199805150-00006",
language = "English (US)",
volume = "65",
pages = "1178--1182",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "9",

}

TY - JOUR

T1 - Timing and severity of initial hepatitis C recurrence as predictors of long-term liver allograft injury

AU - Rosen, Hugo R.

AU - Gretch, David R.

AU - Oehlke, Megan

AU - Flora, Kenneth D.

AU - Benner, Kent G.

AU - Rabkin, John M.

AU - Corless, Christopher

PY - 1998/5/15

Y1 - 1998/5/15

N2 - Background. The majority of patients infected with hepatitis C virus (HCV) undergoing liver transplantation develop evidence of histologic recurrence, and multiple mechanisms are likely poised to affect longterm allograft injury. The purpose of this analysis was to study the hypothesis that histologic and biochemical features at the onset of HCV recurrence predict the long-term evolution of allograft hepatitis. Methods. We studied 34 consecutive liver transplant recipients with evidence of histologic HCV recurrence and with a minimal histologic follow-up of 1 year (up to 6.2 years; mean: 696±83.2 days). Two-hundred and seventy-eight serial allograft biopsies (mean: 6.85±0.62 per patient, range: 4-21) were analyzed. The hepatic activity index was utilized to quantitate piecemeal necrosis, intralobular degeneration, portal inflammation, and hepatic fibrosis. The presence of hepatocyte ballooning degeneration and cholestasis was also assessed. Results. Although there was no significant difference with regard to initial hepatic activity index scores between patients who ultimately developed allograft cirrhosis (group 1; n=8) versus those with milder hepatitis (group 2; n=26), the finding of ballooning degeneration/cholestasis was more frequent in the former group (P=0.04). The distribution of HCV genotypes, the mean follow-up after orthotopic liver transplantation, the mean number of allograft biopsy specimens per patient, basal immunosuppression, and incidence of rejection were comparable in both groups. Patients who ultimately developed allograft cirrhosis had significantly higher initial total bilirubin at the onset of histologic recurrence and peak total bilirubin (pT.Bili, the highest value in the ensuing month). Actuarial rates of moderate-to-severe allograft hepatitis were significantly greater in patients with pT.Bili ≤3.5 mg/dl (P=0.004). Multiple regression analysis identified pT.Bili as the only independent predictor of allograft cirrhosis. Conclusions. Features at the onset of histologic HCV recurrence predict the natural history of allograft injury; specifically, marked, transient hyperbilirubinemia is associated with the subsequent development of allograft cirrhosis.

AB - Background. The majority of patients infected with hepatitis C virus (HCV) undergoing liver transplantation develop evidence of histologic recurrence, and multiple mechanisms are likely poised to affect longterm allograft injury. The purpose of this analysis was to study the hypothesis that histologic and biochemical features at the onset of HCV recurrence predict the long-term evolution of allograft hepatitis. Methods. We studied 34 consecutive liver transplant recipients with evidence of histologic HCV recurrence and with a minimal histologic follow-up of 1 year (up to 6.2 years; mean: 696±83.2 days). Two-hundred and seventy-eight serial allograft biopsies (mean: 6.85±0.62 per patient, range: 4-21) were analyzed. The hepatic activity index was utilized to quantitate piecemeal necrosis, intralobular degeneration, portal inflammation, and hepatic fibrosis. The presence of hepatocyte ballooning degeneration and cholestasis was also assessed. Results. Although there was no significant difference with regard to initial hepatic activity index scores between patients who ultimately developed allograft cirrhosis (group 1; n=8) versus those with milder hepatitis (group 2; n=26), the finding of ballooning degeneration/cholestasis was more frequent in the former group (P=0.04). The distribution of HCV genotypes, the mean follow-up after orthotopic liver transplantation, the mean number of allograft biopsy specimens per patient, basal immunosuppression, and incidence of rejection were comparable in both groups. Patients who ultimately developed allograft cirrhosis had significantly higher initial total bilirubin at the onset of histologic recurrence and peak total bilirubin (pT.Bili, the highest value in the ensuing month). Actuarial rates of moderate-to-severe allograft hepatitis were significantly greater in patients with pT.Bili ≤3.5 mg/dl (P=0.004). Multiple regression analysis identified pT.Bili as the only independent predictor of allograft cirrhosis. Conclusions. Features at the onset of histologic HCV recurrence predict the natural history of allograft injury; specifically, marked, transient hyperbilirubinemia is associated with the subsequent development of allograft cirrhosis.

UR - http://www.scopus.com/inward/record.url?scp=0032525150&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032525150&partnerID=8YFLogxK

U2 - 10.1097/00007890-199805150-00006

DO - 10.1097/00007890-199805150-00006

M3 - Article

C2 - 9603164

AN - SCOPUS:0032525150

VL - 65

SP - 1178

EP - 1182

JO - Transplantation

JF - Transplantation

SN - 0041-1337

IS - 9

ER -